Corpus Intelligence IC Memo — CARLINVILLE AREA HOSPITAL 2026-04-26 16:36 UTC
IC Memo — CARLINVILLE AREA HOSPITAL
Investment Committee Memorandum | IL | 25 beds | Grade C | EBITDA uplift $3.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CARLINVILLE AREA HOSPITAL

CCN 141347 | MACOUPIN, IL | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CARLINVILLE AREA HOSPITAL is a 25-bed rural/critical access in MACOUPIN, IL with $44.6M in net patient revenue and a 1.3% operating margin. The hospital serves a payer mix of 59.7% Medicare, 5.3% Medicaid, and 35.0% commercial.

Thesis: Turnaround. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.3% to 8.7% (+736bps).

Net Revenue HCRIS$44.6M
Current EBITDA COMPUTED$577K
Operating Margin COMPUTED1.3%
Occupancy HCRIS30.3%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS47.8%
Distress Probability ML55.2%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
74
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 1.3% places it above the state median. Among 74 size-comparable peers (12-50 beds), the median margin is -2.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 74 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CARLINVILLE AREA HOSPITAL (Target)IL25$44.6M1.3%
GIBSON AREA HOSPITAL AND HEALTIL25$125.0M-6.7%
GRAHAM HOSPITAL ASSOCIATIONIL43$105.0M-4.7%
PARIS COMMUNITY HOSPITALIL25$100.7M-4.2%
OSF SAINT ANTHONYS HEALTH CENTIL49$91.4M-9.8%
ST. MARGARETS HEALTH - SPRING IL44$88.1M-12.7%
SAINT JOSEPH MEMORIAL HOSPITALIL25$86.0M33.9%
MCDONOUGH DISTRICT HOSPITALIL45$79.6M-4.2%
WABASH GENERAL HOSPITALIL25$71.8M4.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$936K+210bp18mo
Cost to Collect4.5%2.5%$891K+200bp12mo
Denial Rate Reduction12.0%6.5%$882K+198bp12mo
A/R Days Reduction5200.0%3800.0%$542K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$936K
Cost to Collect
$891K
Denial Rate Reduction
$882K
A/R Days Reduction
$542K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.3M
Current EBITDA$577K
+ RCM Uplift+$3.3M
Pro Forma EBITDA$3.9M
Current Margin1.3%
Pro Forma Margin8.7%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$888K$36.6M41.25x110.4%
Base (11x exit)10.0x11.0x$888K$40.6M45.69x114.8%
Bull Case9.0x11.0x$799K$51.7M64.68x130.2%
Bull (12x exit)9.0x12.0x$799K$56.6M70.86x134.5%
Bear Case11.0x10.0x$976K$19.9M20.40x82.8%
Bear (11x exit)11.0x11.0x$976K$22.2M22.77x86.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 59.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 30.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 74 hospitals with 12-50 beds
  • Same-state prioritization (n=75)
  • Comp margins: P25=-7.5% / P50=-2.2% / P75=6.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.